Inactive Instrument

Sector ratings Caplin Point Laboratories Ltd NSE India S.E.

Stocks

End-of-day quote NSE India S.E.
- ^INR	-

08-14	Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026
08-12	Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
SUN PHARMACEUTICAL INDUSTRIES LTD.	48.43B		B
OTSUKA HOLDINGS CO., LTD.	39.72B		A
CIPLA LIMITED	12.25B		A
ZYDUS LIFESCIENCES LIMITED	11.84B		BB
KRKA, D. D.	9.06B		-
GEDEON RICHTER	7.57B		A
ONO PHARMACEUTICAL CO., LTD.	7.18B		AA
GLENMARK PHARMACEUTICALS LIMITED	6.84B		BB
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	5.77B	-	BB	-		-	-
AJANTA PHARMA LIMITED	4.8B		BB
SIMCERE PHARMACEUTICAL GROUP LIMITED	3.97B		A
ASPEN PHARMACARE HOLDINGS LIMITED	3.94B		A
WOCKHARDT LIMITED	3.28B	-	BB	-	-	-	-	-
SAM CHUN DANG PHARM. CO., LTD	3.13B	-	CCC	-	-	-	-	-
ASTRA INDUSTRIAL GROUP COMPANY	2.96B		CCC				-
HAW PAR CORPORATION LIMITED	2.68B	-	-	-		-	-
SUNSHINE LAKE PHARMA CO., LTD.	2.66B	-	B	-	-	-	-
JAMJOOM PHARMACEUTICALS FACTORY COMPANY	2.64B		B	-
APICHOPE PHARMACEUTICAL GROUP CO., LTD.	2.57B	-	-	-		-	-
Average	9.54B		BBB
Weighted average by Cap.			BBB